CanadaBis Capital Inc. (CANB.V)

CAD 0.09

(0.0%)

Total Liabilities Summary of CanadaBis Capital Inc.

  • CanadaBis Capital Inc.'s latest annual total liabilities in 2023 was 15.61 Million CAD , up 21.6% from previous year.
  • CanadaBis Capital Inc.'s latest quarterly total liabilities in 2024 Q2 was 15.21 Million CAD , down -4.34% from previous quarter.
  • CanadaBis Capital Inc. reported annual total liabilities of 12.84 Million CAD in 2022, up 12.05% from previous year.
  • CanadaBis Capital Inc. reported annual total liabilities of 11.46 Million CAD in 2021, up 26.13% from previous year.
  • CanadaBis Capital Inc. reported quarterly total liabilities of 15.05 Million CAD for 2024 Q3, down -1.05% from previous quarter.
  • CanadaBis Capital Inc. reported quarterly total liabilities of 15.21 Million CAD for 2024 Q2, down -4.34% from previous quarter.

Annual Total Liabilities Chart of CanadaBis Capital Inc. (2023 - 2016)

Historical Annual Total Liabilities of CanadaBis Capital Inc. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 15.61 Million CAD 21.6%
2022 12.84 Million CAD 12.05%
2021 11.46 Million CAD 26.13%
2020 9.08 Million CAD 262.6%
2019 2.5 Million CAD 7703.12%
2018 32.12 Thousand CAD 124.54%
2017 14.3 Thousand CAD 0.0%
2016 - CAD 0.0%

Peer Total Liabilities Comparison of CanadaBis Capital Inc.

Name Total Liabilities Total Liabilities Difference
Aequus Pharmaceuticals Inc. 5.38 Million CAD -190.31%
Decibel Cannabis Company Inc. 96.79 Million CAD 83.863%
Delivra Health Brands Inc. 4.85 Million CAD -221.509%
Entourage Health Corp. 178.68 Million CAD 91.259%
Lifeist Wellness Inc. 9.94 Million CAD -57.121%
Cannara Biotech Inc. 61.77 Million CAD 74.718%
Medicure Inc. 8.16 Million CAD -91.338%
PharmaCielo Ltd. 23.96 Million CAD 34.837%
Rubicon Organics Inc. 16.99 Million CAD 8.106%
BioSyent Inc. 6.76 Million CAD -130.735%
Voyageur Pharmaceuticals Ltd. 727.87 Thousand CAD -2045.814%